Opening book details…
About this Medicine article
VANTAGE 014: Vorinostat (V) in Patients With Advanced Malignant Pleural Mesothelioma (MPM) who Have Failed Prior Pemetrexed and Either Cisplatin or Carboplatin Therapy: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial by L.M. Krug; H. Kindler; H. Calvert; C. Manegold; A.S. Tsao; D. Fennell; G.M. Lubiniecki; X. Sun; M. Smith; P. Baas is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- L.M. Krug; H. Kindler; H. Calvert; C. Manegold; A.S. Tsao; D. Fennell; G.M. Lubiniecki; X. Sun; M. Smith; P. Baas
- Publisher
- Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 0959-8049)
- Published
- 2011
- Language
- EN
- Field
- Medicine (Health Sciences)